8-K filed September 3, 2025, 7:59 PM ET CIK 0001119643

other material confidence high sentiment negative materiality 0.80

Nutra Pharma Corp. changes certifying accountant: Marcum LLP resigns, Astra Audit & Advisory engaged

NUTRA PHARMA CORP

Marcum LLP resigned as independent auditor on March 27, 2024, after only reviewing Q2 and Q3 2022 Form 10-Qs.
No disagreements occurred, but Marcum cited material weaknesses including lack of qualified accounting personnel and inadequate segregation of duties.
Astra Audit & Advisory was engaged on December 18, 2024, as new independent registered public accounting firm for FY 2022.
The Company provided Marcum with disclosures; Marcum's letter to the SEC dated September 3, 2025, is filed as Exhibit 16.1.

item 4.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001641172-25-026384
form_type: 8-K
ticker: null
cik: 0001119643
company_name: NUTRA PHARMA CORP
filed_at: 2025-09-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.382206+00:00
generated_at: 2026-05-17T08:27:44.296748+00:00
sec_items: ["4.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001641172-25-026384
json_url: https://secwatch.observer/filing/0001641172-25-026384.json
markdown_url: https://secwatch.observer/filing/0001641172-25-026384.md
text_url: https://secwatch.observer/filing/0001641172-25-026384.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1119643/000164117225026384/0001641172-25-026384-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1119643/000164117225026384/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

708b1464fe858b408e47aaf1b0bba74390f7f46a

Marcum LLP resigned as auditor of NUTRA PHARMA CORP.

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

SEC 8-K Item 4.01/4.02 confidence 0.9 SEC evidence

9a62faefe32419458c1b62460c9d0dcc701d321d

NUTRA PHARMA CORP engaged Astra Audit & Advisory as its auditor.

On December 18, 2024, the Board approved the engagement of Astra Audit & Advisory (“AA”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

SEC 8-K Item 4.01/4.02 confidence 0.9 SEC evidence

Comparable filings

CNTY

Century Casinos dismisses Grant Thornton, appoints EY as new auditor; cites material weaknesses

CENTURY CASINOS INC /CO/ May 28, 2026, 4:11 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

(b) Engagement of Independent Registered Public Accounting Firm On May 22, 2026, the Audit Committee appointed Ernst & Young LLP (“EY”) as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2026.

Filing page SEC filing

ALUR

Allurion Technologies dismisses Deloitte & Touche, appoints CBIZ; discloses material weaknesses

ALLURION TECHNOLOGIES, INC. May 27, 2026, 4:35 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm.

Filing page SEC filing

WAST

Waste Energy Corp. files 8-K/A: auditor Integrität resigned amid disagreement over AZ litigation legal confirmations

WASTE ENERGY CORP. May 27, 2026, 4:33 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

ments contained in Integrität’s correspondence. Except as expressly set forth herein, this Amendment does not amend, update, or change any other items or disclosures contained in the Original Report.

Filing page SEC filing

OCTV

Octave Intelligence completes spin-off from Hexagon; draws $625M credit facility, changes auditor

Octave Intelligence plc May 26, 2026, 6:02 AM ET other_material Items 1.01, 2.03, 4.01, 5.02, 8.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

On May 20, 2026, the Audit Committee of the Board of Directors of the Company (i) dismissed PricewaterhouseCoopers AB (“PwC Sweden”) as the Company’s independent registered public accounting firm (the “Dismissal”) and (ii) appointed PricewaterhouseCoopers LLP, United States (“PwC US”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Appointment”).

Filing page SEC filing

GROO

Groovy Company CEO Abajian exits May 1; accountant dismissed after SEC suspension; authorized common cut to 100M shares

GROOVY COMPANY, INC. May 13, 2026, 2:31 PM ET other_material Items 4.01, 4.02, 5.03, 5.02, 8.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

(a) Dismissal of Previous Independent Registered Public Accounting Firm. On August 13, 2025, the Board of Directors of Groovy Company, Inc.

Filing page SEC filing

QWTR

Quest Water Global's auditor Fruci resigns; no successor yet

Quest Water Global, Inc. May 7, 2026, 7:59 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

On May 5, 2026, and at the request of Quest Water Global, Inc. (the “Company”), Fruci & Associates II, PLLC (“Fruci”) resigned as the Company’s independent accountant.

Filing page SEC filing

MLSS

Milestone Scientific dismisses auditor CBIZ; engages Grassi & Co. effective May 15, 2026

MILESTONE SCIENTIFIC INC. May 6, 2026, 7:59 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

The Company engaged Grassi & Co., CPAs, P.C. to be the independent registered public accounting firm to the Company for

Filing page SEC filing

SONM

DNA X (SONM) dismisses auditor Baker Tilly, engages TAAD; 2025 audit includes going concern

DNA X, Inc. April 30, 2026, 7:59 PM ET other_material Items 4.01, 9.01

same fact type: auditor_change same SEC item: 4.01, 9.01 same event type: other_material similar materiality

This filing

On March 27, 2024, the Audit Committee of the Board of Directors (the “Committee”) of Nutra Pharma Corp. (the “Company”) received a letter indicating the resignation of Marcum LLP (“Marcum”) as the Company’s independent registered public accounting firm.

Comparable filing

On April 27, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of DNA X, Inc. (the “Company”) dismissed Baker Tilly US, LLP (“Baker Tilly”) as the Company’s independent registered public accounting firm.

Filing page SEC filing

Source: SEC EDGAR

accession 0001641172-25-026384

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.